Compound 2252
Identifiers
- Canonical SMILES:
Cn1ncc2cc(ccc12)C(=O)Nc1ccc2[nH]c(CN3CC4CC4C3)nc2c1
- IUPAC name:
N-[2-({3-azabicyclo[3.1.0]hexan-3-yl}methyl)-1H-1,3-benzodiazol-5-yl]-1-methyl-1H-indazole-5-carboxamide
- InChi:
InChI=1S/C22H22N6O/c1-27-20-5-2-13(6-14(20)9-23-27)22(29)24-17-3-4-18-19(8-17)26-21(25-18)12-28-10-15-7-16(15)11-28/h2-6,8-9,15-16H,7,10-12H2,1H3,(H,24,29)(H,25,26)
- InChiKey:
IGZWGTGHJXYZKT-UHFFFAOYSA-N
External links
![]() 168317845 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MLLT1 / H3 | 5.85 | myeloid leukemia | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 386.19 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 2.04 | |||
TPSA | 80.04 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1002/anie.201810617 | 86 | ENL Q03111 |
H31 P68431 |
Biochemical assay | alphascreen | pIC50 (half maximal inhibitory concentration, -log10) | 5.85 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5650 | Dabigatran | DB14726 | |
0.5380 | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | DB07973 | |
0.5361 | 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE | DB07974 | |
0.5283 | Glasdegib | DB11978 | |
0.5267 | 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide | DB07315 | |
0.5207 | Atevirdine | DB12264 | |
0.5152 | USL-311 | DB15265 | |
0.5146 | [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium | DB02269 | |
0.5093 | Niraparib | DB11793 | |
0.5056 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07689 | |
0.5056 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07765 | |
0.5032 | Veliparib | DB07232 | |
0.4947 | Ribociclib | DB11730 | |
0.4944 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DB06938 | |
0.4931 | 3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide | DB03534 |